The effect of CPP in neurogenic pain: inhibition of spinal or cortical NMDA receptors?
Øye
Ivar
I
Department of Pharmacology Oslo University School of Medicine P.B. 1057 Blindern, 0316 Oslo, Norway.
Mathisen
Lene C
LC
D002540:Cerebral Cortex / Q000187:drug effects*; D006801:Humans; D010146:Pain / Q000188:drug therapy*; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use*; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*; D013116:Spinal Cord / Q000187:drug effects*
D010879:Piperazines; D016194:Receptors, N-Methyl-D-Aspartate; C050592:3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid